OCUGEN, INC. Increase (Decrease) in Prepaid Expense and Other Assets
OCUGEN, INC. (OCGN) reported Increase (Decrease) in Prepaid Expense and Other Assets of $900.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-06
- OCUGEN, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$27.00K.
- OCUGEN, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $927.00K, a 69.12% decline year-over-year.
- OCUGEN, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $694.00K, a 48.21% decline year-over-year.
- OCUGEN, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$795.00K.
- OCUGEN, INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $2.61M.
- OCUGEN, INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$361.00K, a 221.96% decline from fiscal 2023.
- OCUGEN, INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $296.00K.
- OCUGEN, INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$91.00K, a 112.26% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$27.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $900.00K 10-Q · filed 2026-08-06 | $1.59M derived: sum of 3 quarters · filed 2026-08-06 | $799.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $927.00K 10-Q · filed 2026-05-08 | $1.62M derived: sum of 2 quarters · filed 2026-05-08 | $826.00K derived: sum of 3 quarters · filed 2026-05-08 | $532.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $694.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$101.00K derived: sum of 2 quarters · filed 2026-03-04 | -$395.00K derived: sum of 3 quarters · filed 2026-08-06 | $2.61M 10-K · filed 2026-03-04 | ||||
| 2025-09-30 | -$795.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$1.09M derived: sum of 2 quarters · filed 2026-08-06 | $1.91M 10-Q · filed 2025-11-05 | $3.25M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | -$294.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.71M 10-Q · filed 2026-08-06 | $4.05M derived: sum of 3 quarters · filed 2026-08-06 | $2.91M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $3.00M 10-Q · filed 2026-05-08 | $4.34M derived: sum of 2 quarters · filed 2026-05-08 | $3.21M derived: sum of 3 quarters · filed 2026-05-08 | $2.52M derived: sum of 4 quarters · filed 2026-05-08 | ||||
| 2024-12-31 | $1.34M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $206.00K derived: sum of 2 quarters · filed 2026-03-04 | -$478.00K derived: sum of 3 quarters · filed 2026-03-04 | -$361.00K 10-K · filed 2026-03-04 | ||||
| 2024-09-30 | -$1.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$1.82M derived: sum of 2 quarters · filed 2025-11-05 | -$1.70M 10-Q · filed 2025-11-05 | -$1.27M derived: sum of 4 quarters · filed 2025-11-05 | ||||
| 2024-06-30 | -$684.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | -$567.00K 10-Q · filed 2025-08-04 | -$139.00K derived: sum of 3 quarters · filed 2025-08-04 | $301.00K derived: sum of 4 quarters · filed 2025-08-04 | ||||
| 2024-03-31 | $117.00K 10-Q · filed 2025-05-09 | $545.00K derived: sum of 2 quarters · filed 2025-05-09 | $985.00K derived: sum of 3 quarters · filed 2025-05-09 | $353.00K derived: sum of 4 quarters · filed 2025-05-09 | ||||
| 2023-12-31 | $428.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $868.00K derived: sum of 2 quarters · filed 2025-03-05 | $236.00K derived: sum of 3 quarters · filed 2025-03-05 | $296.00K 10-K · filed 2025-03-05 | ||||
| 2023-09-30 | $440.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$192.00K derived: sum of 2 quarters · filed 2024-11-14 | -$132.00K 10-Q · filed 2024-11-14 | $1.67M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | -$632.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$572.00K 10-Q · filed 2024-08-08 | $1.23M derived: sum of 3 quarters · filed 2024-08-08 | -$531.00K derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | $60.00K 10-Q · filed 2024-05-14 | $1.86M derived: sum of 2 quarters · filed 2024-05-14 | $101.00K derived: sum of 3 quarters · filed 2024-05-14 | -$606.00K derived: sum of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | $1.80M derived: 10-K 12 month − 10-K 9 month · filed 2024-04-16 | $41.00K derived: sum of 2 quarters · filed 2024-04-16 | -$666.00K derived: sum of 3 quarters · filed 2024-04-16 | -$91.00K 10-K · filed 2024-04-16 | ||||
| 2022-09-30 | -$1.76M derived: 10-K 9 month − 10-K 6 month · filed 2024-04-16 | -$2.46M derived: sum of 2 quarters · filed 2024-04-16 | -$1.89M 10-K · filed 2024-04-16 | -$301.00K derived: sum of 4 quarters · filed 2024-04-16 | ||||
| 2022-06-30 | -$707.00K derived: 10-K 6 month − 10-K 3 month · filed 2024-04-16 | -$132.00K 10-K · filed 2024-04-16 | $1.46M derived: sum of 3 quarters · filed 2024-04-16 | $1.57M derived: sum of 4 quarters · filed 2024-04-16 | ||||
| 2022-03-31 | $575.00K 10-K · filed 2024-04-16 | $2.16M derived: sum of 2 quarters · filed 2024-04-16 | $2.28M derived: sum of 3 quarters · filed 2024-04-16 | $1.81M derived: sum of 4 quarters · filed 2024-04-16 | ||||
| 2021-12-31 | $1.59M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $1.71M derived: sum of 2 quarters · filed 2023-02-28 | $1.24M derived: sum of 3 quarters · filed 2023-02-28 | $742.00K 10-K · filed 2023-02-28 | ||||
| 2021-09-30 | $120.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$352.00K derived: sum of 2 quarters · filed 2022-11-08 | -$845.00K 10-Q · filed 2022-11-08 | $321.00K derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2021-06-30 | -$472.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | -$965.00K 10-Q · filed 2022-08-05 | $201.00K derived: sum of 3 quarters · filed 2022-08-05 | -$95.00K derived: sum of 4 quarters · filed 2022-08-05 | ||||
| 2021-03-31 | -$493.00K 10-Q · filed 2022-05-06 | $673.00K derived: sum of 2 quarters · filed 2022-05-06 | $377.00K derived: sum of 3 quarters · filed 2022-05-06 | $105.00K derived: sum of 4 quarters · filed 2022-05-06 | ||||
| 2020-12-31 | $1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $870.00K derived: sum of 2 quarters · filed 2022-02-28 | $598.00K derived: sum of 3 quarters · filed 2022-02-28 | $370.00K 10-K · filed 2022-02-28 | $369.85K 10-K · filed 2021-03-19 | |||
| 2020-09-30 | -$296.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$568.00K derived: sum of 2 quarters · filed 2021-11-09 | -$796.00K 10-Q · filed 2021-11-09 | -$794.40K 10-Q · filed 2020-11-06 | -$69.84K derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2020-06-30 | -$272.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | -$500.00K 10-Q · filed 2021-08-06 | -$498.84K 10-Q · filed 2020-08-14 | $226.16K derived: sum of 3 quarters · filed 2022-02-28 | $474.01K derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2020-03-31 | -$228.00K 10-Q · filed 2021-05-07 | -$227.87K 10-Q · filed 2020-05-08 | $498.16K derived: sum of 2 quarters · filed 2022-02-28 | $746.01K derived: sum of 3 quarters · filed 2022-02-28 | $828.55K derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2019-12-31 | $726.16K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $974.01K derived: sum of 2 quarters · filed 2022-02-28 | $1.06M derived: sum of 3 quarters · filed 2022-02-28 | $1.01M 10-K · filed 2022-02-28 | $1.01M 10-K · filed 2020-03-27 | |||
| 2019-09-30 | $247.85K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $330.39K derived: sum of 2 quarters · filed 2020-11-06 | $280.84K 10-Q · filed 2020-11-06 | $315.61K 10-Q · filed 2019-11-12 | $92.16K derived: sum of 4 quarters · filed 2020-11-06 | |||
| 2019-06-30 | $82.54K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $32.99K 10-Q · filed 2020-08-14 | -$386.00K 10-Q · filed 2019-08-09 | -$155.69K derived: sum of 3 quarters · filed 2020-08-14 | $218.98K derived: sum of 4 quarters · filed 2020-08-14 | |||
| 2019-03-31 | -$49.55K 10-Q · filed 2020-05-08 | -$94.00K 10-Q · filed 2019-05-15 | -$238.24K derived: sum of 2 quarters · filed 2020-05-08 | $136.44K derived: sum of 3 quarters · filed 2020-05-08 | -$511.69K derived: sum of 4 quarters · filed 2020-05-08 | |||
| 2018-12-31 | -$188.68K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $185.99K derived: sum of 2 quarters · filed 2020-03-27 | -$462.14K derived: sum of 3 quarters · filed 2020-03-27 | $201.86K 10-K · filed 2020-03-27 | $664.00K 10-K · filed 2019-03-22 | |||
| 2018-09-30 | $374.67K derived: 10-Q 9 month − 8-K/A 6 month · filed 2019-11-12 | -$273.46K derived: sum of 2 quarters · filed 2019-11-12 | $390.54K 10-Q · filed 2019-11-12 | $631.00K 10-Q · filed 2018-11-08 | $326.54K derived: sum of 4 quarters · filed 2019-11-12 | |||
| 2018-06-30 | -$648.13K derived: 8-K/A 6 month − 10-Q 3 month · filed 2019-10-07 | $15.87K 8-K/A · filed 2019-10-07 | $687.00K 10-Q · filed 2018-08-09 | -$48.13K derived: sum of 3 quarters · filed 2019-10-07 | -$94.13K derived: sum of 4 quarters · filed 2019-10-07 | |||
| 2018-03-31 | $664.00K 10-Q · filed 2019-05-15 | $600.00K derived: sum of 2 quarters · filed 2019-05-15 | $554.00K derived: sum of 3 quarters · filed 2019-05-15 | $563.00K derived: sum of 4 quarters · filed 2019-05-15 | ||||
| 2017-12-31 | -$64.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | -$110.00K derived: sum of 2 quarters · filed 2019-03-22 | -$101.00K derived: sum of 3 quarters · filed 2019-03-22 | $21.00K 10-K · filed 2019-03-22 | ||||
| 2017-09-30 | -$46.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$37.00K derived: sum of 2 quarters · filed 2018-11-08 | $85.00K 10-Q · filed 2018-11-08 | $57.00K derived: sum of 4 quarters · filed 2018-11-08 | ||||
| 2017-06-30 | $9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $131.00K 10-Q · filed 2018-08-09 | $103.00K derived: sum of 3 quarters · filed 2018-08-09 | -$46.00K derived: sum of 4 quarters · filed 2018-08-09 | ||||
| 2017-03-31 | $122.00K 10-Q · filed 2018-05-10 | $94.00K derived: sum of 2 quarters · filed 2018-05-10 | -$55.00K derived: sum of 3 quarters · filed 2018-05-10 | -$171.00K derived: sum of 4 quarters · filed 2018-05-10 | ||||
| 2016-12-31 | -$28.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -$177.00K derived: sum of 2 quarters · filed 2018-03-15 | -$293.00K derived: sum of 3 quarters · filed 2018-03-15 | -$148.00K 10-K · filed 2018-03-15 | ||||
| 2016-09-30 | -$149.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$265.00K derived: sum of 2 quarters · filed 2017-11-09 | -$120.00K 10-Q · filed 2017-11-09 | -$164.00K derived: sum of 4 quarters · filed 2017-11-09 | ||||
| 2016-06-30 | -$116.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $29.00K 10-Q · filed 2017-08-10 | -$15.00K derived: sum of 3 quarters · filed 2017-08-10 | -$547.00K derived: sum of 4 quarters · filed 2017-08-10 | ||||
| 2016-03-31 | $145.00K 10-Q · filed 2017-05-11 | $101.00K derived: sum of 2 quarters · filed 2017-05-11 | -$431.00K derived: sum of 3 quarters · filed 2017-05-11 | -$363.00K derived: sum of 4 quarters · filed 2017-05-11 | ||||
| 2015-12-31 | -$44.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | -$576.00K derived: sum of 2 quarters · filed 2017-03-16 | -$508.00K derived: sum of 3 quarters · filed 2017-03-16 | -$475.00K 10-K · filed 2017-03-16 | ||||
| 2015-09-30 | -$532.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$464.00K derived: sum of 2 quarters · filed 2016-11-10 | -$431.00K 10-Q · filed 2016-11-10 | -$377.00K derived: sum of 4 quarters · filed 2016-11-10 | ||||
| 2015-06-30 | $68.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $101.00K 10-Q · filed 2016-08-11 | $155.00K derived: sum of 3 quarters · filed 2016-08-11 | $471.00K derived: sum of 4 quarters · filed 2016-08-11 | ||||
| 2015-03-31 | $33.00K 10-Q · filed 2016-05-12 | $87.00K derived: sum of 2 quarters · filed 2016-05-12 | $403.00K derived: sum of 3 quarters · filed 2016-05-12 | $502.00K derived: sum of 4 quarters · filed 2016-05-12 | ||||
| 2014-12-31 | $54.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $370.00K derived: sum of 2 quarters · filed 2016-03-10 | $469.00K derived: sum of 3 quarters · filed 2016-03-10 | $226.00K 10-K · filed 2016-03-10 | ||||
| 2014-09-30 | $316.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $415.00K derived: sum of 2 quarters · filed 2015-11-12 | $172.00K 10-Q · filed 2015-11-12 | |||||
| 2014-06-30 | $99.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | -$144.00K 10-Q · filed 2015-08-12 | ||||||
| 2014-03-31 | -$243.00K 10-Q · filed 2015-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |